InvestorsHub Logo
Followers 3
Posts 609
Boards Moderated 0
Alias Born 11/09/2017

Re: CanadaGreece post# 49224

Thursday, 08/08/2019 5:15:42 PM

Thursday, August 08, 2019 5:15:42 PM

Post# of 50157
Six months ended June 30, 2019 and June 30, 2018
Revenue
The Company recorded approximately $0.3 million in revenue related to product sales for the six months ended June 30, 2019 and $1.6 million in revenue
related to product sales for the six months ended June 30, 2018. The decrease was slightly offset by $0.4 million in other revenue. Other revenue and the
decrease in product revenue are both related to the Company entering into a licensing agreement with medac as discussed further in the Market Access and
Commercial Clinical Adoption section above.

My opinion is not a recommendation to buy or sell any security. Your decision whether or not to make a purchase or sell should be based on your own due diligence.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent DCTH News